Matches in Wikidata for { <http://www.wikidata.org/entity/Q66387952> ?p ?o ?g. }
Showing items 1 to 35 of
35
with 100 items per page.
- Q66387952 description "clinical trial" @default.
- Q66387952 description "ensayu clínicu" @default.
- Q66387952 description "klinisch onderzoek" @default.
- Q66387952 description "клінічне випробування" @default.
- Q66387952 name "Dose-Ranging Study of ST-920, a rAAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease" @default.
- Q66387952 name "Dose-Ranging Study of ST-920, a rAAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease" @default.
- Q66387952 type Item @default.
- Q66387952 label "Dose-Ranging Study of ST-920, a rAAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease" @default.
- Q66387952 label "Dose-Ranging Study of ST-920, a rAAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease" @default.
- Q66387952 prefLabel "Dose-Ranging Study of ST-920, a rAAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease" @default.
- Q66387952 prefLabel "Dose-Ranging Study of ST-920, a rAAV2/6 Human Alpha Galactosidase A Gene Therapy in Subjects With Fabry Disease" @default.
- Q66387952 P1050 Q66387952-5F7FFB31-A55E-438D-8333-1B1EF91A308B @default.
- Q66387952 P1132 Q66387952-70B0BBC9-5764-4D22-B24B-BC7243389C38 @default.
- Q66387952 P1476 Q66387952-0AFBF6D6-93F0-4EA2-8F73-CEC6E574D605 @default.
- Q66387952 P17 Q66387952-FE8D6A7B-D0E3-4C85-965C-C0E992FE9222 @default.
- Q66387952 P2899 Q66387952-0092AE71-A2B1-4AF9-BE79-08AA7D864B74 @default.
- Q66387952 P3098 Q66387952-6CDD2DA2-3B2E-420B-AD74-3EACB4B554BC @default.
- Q66387952 P31 Q66387952-21188C23-2C05-4681-B6E7-A98583C03972 @default.
- Q66387952 P580 Q66387952-4685BF1F-3AE3-44D2-913A-ECFC9E9DE44A @default.
- Q66387952 P582 Q66387952-977FCA29-166C-4644-9E8A-9A724CB97AAF @default.
- Q66387952 P6099 Q66387952-3E995976-7928-4BF9-A5C7-3E11697E0EF7 @default.
- Q66387952 P6099 Q66387952-848A7457-C0DD-43F9-A945-54D394CCD2B2 @default.
- Q66387952 P8363 Q66387952-C5745C61-58CD-46DB-8276-552699E2AEA9 @default.
- Q66387952 P1050 Q615645 @default.
- Q66387952 P1132 "+18" @default.
- Q66387952 P1476 "A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, a rAAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease" @default.
- Q66387952 P17 Q30 @default.
- Q66387952 P2899 "+18" @default.
- Q66387952 P3098 "NCT04046224" @default.
- Q66387952 P31 Q30612 @default.
- Q66387952 P580 "2019-07-23T00:00:00Z" @default.
- Q66387952 P582 "2021-09-28T00:00:00Z" @default.
- Q66387952 P6099 Q42824440 @default.
- Q66387952 P6099 Q5452194 @default.
- Q66387952 P8363 Q78089383 @default.